+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Breast Implants Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report (2026-2035)

  • PDF Icon

    Report

  • 350 Pages
  • May 2026
  • Region: Global
  • Expert Market Research
  • ID: 5797978
The breast implants market was valued at USD 2.70 Billion in 2025. It is poised to grow at a CAGR of 8.40% during the forecast period of 2026-2035, and reach USD 6.05 Billion by 2035. The market growth is driven by the rising demand for aesthetic procedures, increasing awareness, technological advancements in implants, growing disposable income, and expanding medical tourism across emerging and developed healthcare markets globally.

Latest News on the Breast Implants Market (2026)

  • In April 2026, Allergan Aesthetics promoted its Natrelle® breast implants through a patient-awareness campaign highlighting real-world augmentation outcomes and transparency in procedures.
  • In March 2026, Establishment Labs highlighted the continued expansion of its Motiva implant portfolio in the U.S., emphasizing innovation and increasing adoption following recent regulatory progress.
  • In February 2026, Applied Medical Technology Inc. received FDA 510(k) clearance for the Explant Express® device, designed to improve safety and efficiency in breast implant removal procedures.

Key Market Trends and Insights

  • By product type, the silicone breast implants segment is likely to dominate with more than 83% market share in the historical period.
  • By shape, the round implants segment is likely to lead with above 80% market share in the historical period.
  • By region, the North America segment is likely to dominate with about 31% of market share in the historical period.

Market Size and Forecast

  • Market Size (2025): USD 2.70 Billion
  • Projected Market Size (2035): USD 6.05 Billion
  • CAGR (2026-2035): 8.40%

Breast Implants Market Overview

The market is witnessing steady growth, driven by increasing demand for cosmetic and reconstructive procedures. Rising awareness, technological advancements in implant materials, and improving surgical outcomes are supporting adoption. Expanding medical tourism and higher disposable incomes in emerging economies further contribute to growth, while regulatory approvals and product innovations continue to shape the competitive landscape globally. The market reached a value of approximately USD 2.70 Billion in 2025.

Breast Implants Market Growth Drivers

Technological Advancements Driving the Market Growth and Procedural Innovation

Increasing demand for safer surgical outcomes and rising awareness of aesthetic procedures are key drivers supporting market expansion. For instance, in February 2026, Applied Medical Technology received FDA clearance for a breast implant removal device. This advancement enhances surgical safety, improving procedural efficiency and patient outcomes, thereby supporting steady growth across the market.

Breast Implants Market Trends

Breast implants market trends include rising demand for minimally invasive procedures, advancements in implant materials, increasing safety awareness, and growing medical tourism.

Innovation and Portfolio Expansion Shaping the Emerging Market Advancement

Growing focus on product innovation and expanding patient awareness are key trends influencing the market landscape. For instance, in March 2026, Establishment Labs expanded Motiva implant adoption in the United States. This development strengthens product innovation, improving aesthetic outcomes and adoption rates, ultimately shaping evolving trends and enhancing competitive positioning within the global market.

Breast Implants Market Segmentation

Market Breakup by Shape

  • Round Breast Implants
  • Anatomical Breast Implants

Market Breakup by Product Type

  • Silicone Breast Implant
  • Saline Breast Implant

Market Breakup by Application

  • Cosmetic Surgery
  • Reconstructive Surgery

Market Breakup by End Use

  • Hospitals
  • Cosmetology Clinics
  • Ambulatory Surgical Centers

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Breast Implant Market Share

Round Implants Segment Likely to Lead the Market by Shape

The round implants segment is likely to lead the market by shape, accounting for approximately 80% share in the historical period. This dominance is supported by widespread surgeon preference, consistent aesthetic outcomes, and patient demand for fuller contours. Advancements in implant design further enhance durability, safety, and procedural predictability, reinforcing the segment’s strong positioning across global cosmetic and reconstructive applications.

Breast Implants Market Analysis by Region

North America segment is likely to dominate the market by region, holding around 31% share in the historical period. Growth is supported by high procedure volumes, advanced healthcare infrastructure, and strong presence of leading manufacturers. Increasing adoption of cosmetic procedures and rising consumer awareness continue to strengthen regional demand, maintaining its dominant position within the market.

Leading Players in the Breast Implants Market

The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Allergan plc

Founded in 1948 and headquartered in Dublin, Ireland, Allergan plc is a leading pharmaceutical company specializing in medical aesthetics. Its portfolio includes breast implants, particularly the Natrelle line, widely used in cosmetic and reconstructive procedures. The company leverages aesthetic innovation to enhance product safety and outcomes. In 2020, AbbVie completed its acquisition of Allergan.

CEREPLAS company

Established in 2007 and headquartered in France, CEREPLAS focuses on manufacturing breast implants and tissue expanders for reconstructive and aesthetic surgery. Its portfolio emphasizes biocompatible materials and advanced implant technologies. The company supports implant safety through rigorous quality standards and innovation, catering to global plastic surgery markets with expanding international presence.

GC Aesthetics PLC

Founded in 1979 and headquartered in Dublin, Ireland, GC Aesthetics PLC develops and markets breast implants and aesthetic solutions globally. Its portfolio includes silicone gel implants and reconstruction products. The company prioritizes silicone implants development to improve durability and patient satisfaction.

Sientra Inc.

Established in 2007 and headquartered in Santa Barbara, California, Sientra Inc. specializes in breast implants and body contouring solutions. Its portfolio includes silicone gel implants designed for safety and performance. The company focuses on breast reconstruction advancements and surgeon partnerships. In 2024, Sientra announced strategic initiatives to strengthen its aesthetics business.

Other key players in the market are POLYTECH Health & Aesthetics GmbH, Hans Biomed Co., Ltd., Medical Devices Business Services, Inc. (Johnson & Johnson), Groupe Sebbin SAS, Mentor Worldwide LLC, Establishment Labs S.A., Shanghai Kangning Medical Supplies Ltd., and LABORATOIRES ARION.

Key Questions Answered in the Breast Implants Market Report

  • What was the breast implants market value in 2025?
  • What is the breast implants market forecast outlook for 2026-2035?
  • What major factors aid the demand for the breast implants market?
  • How has the market performed so far, and how is it anticipated to perform in the coming years?
  • What are the market’s major drivers, opportunities, and restraints?
  • What are the major breast implants market trends?
  • Which shape is expected to dominate the market segment?
  • Which product type is expected to dominate the market segment?
  • Which application is expected to dominate the market segment?
  • Which end use is expected to dominate the market segment?
  • Who are the key players in the breast implants market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Breast Implant Market Overview
3.1 Global Breast Implant Market Historical Value (2019-2025)
3.2 Global Breast Implant Market Forecast Value (2026-2035)
4 Global Breast Implant Market Landscape
4.1 Global Breast Implant Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Breast Implant Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Applications
4.2.3 Analysis by End User
5 Global Breast Implant Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Breast Implant Market Segmentation
6.1 Global Breast Implant Market by Shape
6.1.1 Market Overview
6.1.2 Round Breast Implants
6.1.3 Anatomical Breast Implants
6.2 Global Breast Implant Market by Product Type
6.2.1 Market Overview
6.2.2 Silicone Breast Implant
6.2.3 Saline Breast Implant
6.3 Global Breast Implant Market by Application
6.3.1 Market Overview
6.3.2 Cosmetic Surgery
6.3.3 Reconstructive Surgery
6.4 Global Breast Implant Market by End Use
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Cosmetology Clinics
6.4.4 Ambulatory Surgical Centers
6.5 Global Breast Implant Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Breast Implant Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Breast Implant Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Breast Implant Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Breast Implant Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Breast Implant Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Allergan plc
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 CEREPLAS company
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 GC Aesthetics PLC
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Sientra Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 POLYTECH Health & Aesthetics GmBH
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Hans Biomed Co., Ltd.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Medical Devices Business Services, Inc. (Johnson & Johnson)
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Groupe Sebbin SAS
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Mentor Worldwide LLC
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 LABORATOIRES ARION
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Establishment Labs S.A.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Shanghai Kangning Medical Supplies Ltd.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
18 Global Breast Implant Market- Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Allergan plc
  • CEREPLAS company
  • GC Aesthetics PLC
  • Sientra Inc.